Cara Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 15,006 | 0.0274% |
Individual Insiders | 496,221 | 0.908% |
Public Companies | 7,396,770 | 13.5% |
General Public | 19,638,248 | 35.9% |
Institutions | 27,120,834 | 49.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,396,770 | US$5.5m | 0% | no data | |||
3,421,363 | US$2.6m | -3.74% | no data | |||
2,481,258 | US$1.9m | -5.69% | no data | |||
1,812,100 | US$1.4m | 2.24% | 0.02% | |||
1,752,112 | US$1.3m | -0.26% | 0.24% | |||
1,556,251 | US$1.2m | -6.62% | 0.01% | |||
1,548,893 | US$1.2m | 0% | 1.06% | |||
1,020,878 | US$766.0k | 10.3% | no data | |||
1,008,959 | US$757.0k | 3.71% | no data | |||
909,177 | US$682.2k | 11.1% | 0.25% | |||
831,849 | US$624.1k | 3.53% | no data | |||
828,799 | US$621.8k | 28.1% | no data | |||
697,030 | US$523.0k | 123% | no data | |||
696,868 | US$522.9k | -51.7% | no data | |||
637,107 | US$478.0k | 66.4% | no data | |||
550,029 | US$412.7k | 41% | no data | |||
514,200 | US$385.8k | 274% | no data | |||
512,213 | US$384.3k | 0% | 0.14% | |||
467,187 | US$350.5k | -39.7% | no data | |||
391,812 | US$294.0k | -6.09% | no data | |||
334,231 | US$250.8k | -7.28% | no data | |||
328,791 | US$246.7k | 22.4% | no data | |||
313,058 | US$234.9k | 59.4% | no data | |||
307,271 | US$230.5k | 340% | no data | |||
286,205 | US$214.7k | -2.27% | no data |